skip to main content
Show Results with:

Plasma proteomics in CML patients before and after initiation of tyrosine kinase inhibitor therapy reveals induced Th1 immunity and loss of angiogenic stimuli

Söderlund, Stina et al.

Leukemia research. Volume 50 (2016, November); pp 95-103 -- Elsevier

Online access

Searching Remote Databases, Please Wait